ANPAC BIO-MEDICAL SCIENC-ADR (ANPC)
US03635R2067 - ADR
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 7.58M | 9.25M | 3.02M | 6.13M | 12.89M | |||
| Receivables | 25.66M | 12.31M | 14.66M | 2.94M | 5.83M | |||
| Inventories | 384.00K | 490.00K | 310.00K | 310.00K | 60.00K | |||
| Other Current Assets | 3.39M | 1.50M | 3.30M | 12.79M | 2.08M | |||
| Total Current Assets | 37.02M | 23.55M | 21.29M | 22.17M | 20.85M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.73M | 20.26M | 19.27M | 18.87M | 18.14M | |||
| Investments And Advances | 855.00K | 923.00K | 880.00K | 2.33M | 3.46M | |||
| Goodwill | 0.00 | 12.76M | 2.22M | 2.22M | 2.22M | |||
| Intangibles | 1.33M | 9.99M | 5.76M | 6.39M | 6.63M | |||
| Other Non-Current Assets | 8.55M | 0.00 | 460.00K | 1.00M | 1.46M | |||
| Total Non-Current Assets | 29.46M | 43.94M | 28.60M | 30.81M | 31.91M | |||
| TOTAL ASSETS | 66.48M | 67.49M | 49.89M | 52.98M | 52.76M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 16.00K | 33.76M | 8.23M | 38.57M | 25.96M | |||
| Accrued Expenses | 44.41M | 17.54M | 23.38M | 15.50M | 9.26M | |||
| Accounts Payable | 5.30M | 2.73M | 2.13M | 1.80M | 1.62M | |||
| Other Current Liabilities | 6.42M | 8.87M | 9.78M | 10.33M | 34.60M | |||
| Total Current Liabilities | 56.15M | 62.91M | 43.52M | 66.20M | 71.44M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | 2.16M | 1.05M | 1.13M | 1.22M | |||
| Other Non-Current Liabilities | 8.84M | 1.11M | 2.04M | 1.58M | 2.50M | |||
| Total Non-Current Liabilities | 13.67M | 9.08M | 3.42M | 2.76M | 3.72M | |||
| TOTAL LIABILITIES | 69.81M | 71.99M | 46.94M | 68.96M | 75.16M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -545.63M | -475.65M | -356.95M | -276.48M | -174.35M | |||
| Additional Paid In Capital | 536.52M | 465.33M | 354.30M | 257.74M | 152.37M | |||
| Minority Interest | 5.24M | 7.21M | 420.00K | 610.00K | 230.00K | |||
| Common Shares | 2.73M | 1.28M | 810.00K | 660.00K | 570.00K | |||
| Other Shareholders' Equity | 3.05M | 4.53M | 4.80M | 2.11M | -980.00K | |||
| Shares Outstanding | 41.33M | 19.38M | 12.06M | 9.87M | 11.53M | |||
| Tangible Book Value per Share | -0.11 | -1.41 | -0.42 | -2.49 | -2.71 | |||
| Total Shareholders' Equity | -3.34M | -4.50M | 2.95M | -15.97M | -22.39M | |||
| TOTAL LIABILITIES AND EQUITY | 66.48M | 67.49M | 49.89M | 52.98M | 52.76M | |||
| Statistics | ||||||||
| Current Ratio | 0.66 | 0.37 | 0.49 | 0.33 | 0.29 | |||
| Return On Assets (ROA) | -152.07% | -175.87% | -161.31% | -190.75% | -79.72% | |||
| Return On Equity (ROE) | N/A | N/A | -2728.14% | N/A | N/A | |||
All data in CNY